07th April 2022 | Pharma Updates
The first XE variation in India has been recorded in Mumbai
In Mumbai, the first instance of XE, a more transmissible Covid-19 variant, was discovered. A case of the Kappa variant was also discovered during a sero survey, who added that the data came from genome sequencing of 376 samples.
As per WHO, XE is unlikely to have a Delta-like impact in India
Dr. Soumya Swaminathan, top scientist at the WHO, stated that new Covid-19 variations are unlikely to have a Delta-like impact in India due to the country’s high immunisation rate.
Fungi could be the genesis of our next pandemic
COVID-19 elevated public awareness of the dangers posed by zoonotic viruses, which spread from animals to humans. However, focusing solely on viruses risks diverting attention and resources away from other microbial dangers, including deadly fungi.
Lupin signed a licence agreement with Alvion to market pharmaceuticals in Southeast Asia
Lupin will play an important role in enhancing healthcare quality and access to medications. Lupin Limited, a global pharmaceutical company, has announced a licencing arrangement with Alvion Pharmaceuticals P.C.
Dr. Reddy's develops generic Methylprednisolone Sodium Succinate for injection in the US
Dr. Reddy’s Laboratories has announced the debut of its generic Methylprednisolone Sodium Succinate for Injection in the US market, which is approved for a variety of illnesses such as arthritis, blood problems, and severe allergic responses.
Following FDA assay response, the path cleared for Iovance's primary melanoma drug
FDA has cleared the way for Iovance to resume work on an approval application for its primary melanoma drug, lifileucel, which was halted about a year ago when the agency wanted more assay data.
FDA approved antibiotic-embedded hernia mesh to fight implant infections
Ariste Medical recently received FDA 510(k) approval for its drug-embedded polypropylene hernia mesh, to prevent contamination by MRSA, E. coli, and other bacterial pathogens associated with surgery site infections.
FDA approved a second Moderna Booster & Biden administration looking to fix the Affordable Care Act
FDA approved a second Moderna Booster based on Israeli Omicron trials, and the Biden Administration is working to improve the Affordable Care Act and increase subsidised coverage for millions of Americans.
FDA approves Baxter's in-hospital dialysis system
In comparison to the torrent of EUA issued by the FDA during the COVID-19 pandemic, the number of tests and devices that have received full, non-pandemic clearance from the FDA appears to be a trickle.
USFDA granted an EUA for the Helix COVID-19 self-collection kit
USFDA has granted Helix’s SARS-CoV-2 Test and Helix COVID-19 Self-Collection Kit for use with a Locker System EUA.The test is intended to detect nucleic acid from SARS-CoV-2 in anterior nasal swab specimens in a qualitative manner.
